Dietary AhR Ligands Have No Anti-Fibrotic Properties in TGF-β1-Stimulated Human Colonic Fibroblasts

Background: Intestinal fibrosis is a common complication in inflammatory bowel disease (IBD) patients without specific treatment. Aryl hydrocarbon receptor (AhR) activation is associated with better outcomes in intestinal inflammation. Development of novel therapies targeting fibrogenic pathways is...

Descripción completa

Detalles Bibliográficos
Autores principales: Amamou, Asma, Yaker, Linda, Leboutte, Mathilde, Bôle-Feysot, Christine, Savoye, Guillaume, Marion-Letellier, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412321/
https://www.ncbi.nlm.nih.gov/pubmed/36014759
http://dx.doi.org/10.3390/nu14163253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412321/
https://www.ncbi.nlm.nih.gov/pubmed/36014759
http://dx.doi.org/10.3390/nu14163253

Ejemplares similares